Lexeo Therapeutics, Inc. (LXEO) Enterprise Value (2022 - 2023)
Lexeo Therapeutics' Enterprise Value history spans 2 years, with the latest figure at -$35.4 million for Q3 2023.
- For Q3 2023, Enterprise Value rose 62.35% year-over-year to -$35.4 million; the TTM value through Sep 2023 reached -$35.4 million, up 62.35%, while the annual FY2022 figure was -$77.3 million, N/A changed from the prior year.
- Enterprise Value for Q3 2023 was -$35.4 million at Lexeo Therapeutics, up from -$77.3 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$35.4 million in Q3 2023 and bottomed at -$94.2 million in Q3 2022.